Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,46 USD | -10,43% |
|
-11,52% | +3,55% |
Attività
Numero di dipendenti: 58
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 10 | 100,0 % | 0 | 100,0 % | -96,60% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 0 | 100,0 % | -96,60% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 30/03/16 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 30/07/18 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/15 |
Ashlee Dunston
IRC | Investor Relations Contact | - | 01/04/20 |
Peter Villiger
PRN | Corporate Officer/Principal | - | 01/05/16 |
Human Resources Officer | - | 24/12/21 | |
General Counsel | - | 06/10/21 | |
Leslie Nangle
PRN | Corporate Officer/Principal | - | - |
Nancy Krueger
LAW | General Counsel | 56 | 01/10/14 |
Andrew B. Cubitt
PRN | Corporate Officer/Principal | - | 01/09/11 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 08/09/05 |
Tim Coughlin
CHM | Chairman | 57 | 10/04/17 |
John Clarke
BRD | Director/Board Member | 70 | 01/09/05 |
Sara Zaknoen
BRD | Director/Board Member | 65 | 25/05/21 |
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 30/03/16 |
Jane Gross
BRD | Director/Board Member | 67 | 28/06/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 69 010 940 | 67 198 938 ( 97,37 %) | 0 | 97,37 % |
Coordinate società
aTyr Pharma, Inc.
10240 Sorrento Valley Road Suite 300
92121, San Diego
+858 731 8389
http://www.atyrpharma.com![Indirizzo aTyr Pharma, Inc.(ATYR)](https://cdn.zonebourse.com/static/address/60951391.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+3,55% | 112 Mln | |
+38,36% | 52,5 Mrd | |
+36,73% | 39,31 Mrd | |
-8,63% | 39,01 Mrd | |
+25,46% | 28,2 Mrd | |
-11,17% | 26,57 Mrd | |
+11,44% | 26,2 Mrd | |
+45,09% | 14,15 Mrd | |
+32,93% | 12,62 Mrd | |
-5,30% | 11,74 Mrd |
- Borsa valori
- Azioni
- Azione ATYR
- Società aTyr Pharma, Inc.